Infusion Biosciences Announces Second Commercial Launch of Infuz2O Beverage in the US

NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES

TORONTO--(BUSINESS WIRE)--Infusion Biosciences Inc. (“Infusion Biosciences”), a biotechnology company focused on discovering and commercializing innovative hemp and cannabis products, is pleased to announce an additional commercial launch of a beverage utilizing its proprietary water-soluble hemp extract ingredient, Infuz₂O, in the United States with Select Juice, LLC under the brand RIJUICE (the “Infuz₂O Beverage”), a leading producer of fresh-pressed juice products based in Lancaster County, Pennsylvania. Working with Infusion Biosciences, RIJUICE has brought to market beverages (hemp.rijuice.com) that utilize industrial hemp Infuz2O and L-Theanine, a natural ingredient present in green tea. RIJUICE Hemp Infusions contain all-natural ingredients with only 60 calories or less per bottle and are available in three flavors, Strawberry Hibiscus, Mandarin Tranquility, and Lifting Lemon Ginger. Hemp Fusions are manufactured in RIJUICE’s facility located in Lancaster County, Pennsylvania and distributed throughout the Northeastern USA.

“The launch of Hemp Infusions with RIJUICE provides additional commercial validation of our APP Technology and the versatility of Infuz₂O applications in multiple beverage matrices,” said Dr. Arup Sen, CEO and Director. “Formulation of Infuz₂O in fresh-pressed juice products demonstrates a broader market application of APP Technology’s ingredients in beverages that are all natural; these formulation knowhow will be used by Sproutly Canada Inc. (CSE: SPR), the licensee of APP Technology in Canada, to produce multiple categories of beverages,” added Dr. Sen.

"After working with Infuz₂O for more than a year, we are delighted with the results and the ability to incorporate it into fresh juice-based beverages to deliver unique experiences. We are now proceeding with additional formulations to capitalize on our success and recently expanded manufacturing capacity to produce these types of products,” said Mr. Sean Wainwright, CEO of RIJUICE.

“BMC is happy to be assisting RIJUICE to bring innovative, natural beverages with unique functions using ingredients made by Infusion Biosciences’ APP Technology and see these products meet the growing desire of beverage consumers,” commented Mr. Brian Sudano of Beverage Marketing Corporation (www.beveragemarketing.com), the leading consulting, research and advisory services firm dedicated to the global beverage industry.

About RUJUICE

RUICE is a flavor-forward premium juice company that proudly serves the health and wellbeing of its customers by offering unique blends made with only the best ingredients. Their carefully crafted juices are born in Lancaster County - home of America's most fertile farmland. It is their belief that better soil, better plants, and better farming practices make its product unparalleled in both taste and nutritional value. For more information, visit www.rijuice.com.

About Sproutly Canada, Inc.

Sproutly trades on the CSE under the ticker CSE:SPR, its core objective is to become the leading supplier of unique ingredients and customized formulations to the cannabis beverage and edibles market. Its water-soluble Infuz2O and BioNatural Oils will deliver revolutionary brands to international markets that are striving to produce differentiated consumer products. Sproutly’s business focus is to execute on partnerships with local and globally established consumer brands to leverage their existing customer bases, further expand brand loyalty, assist with marketing, and support distribution networks to deliver this scientific breakthrough with speed and efficiency worldwide. For more information, visit www.sproutly.ca.

About Infusion Biosciences Inc.

Infusion Biosciences Inc. is a biotechnology company focused on discovering and commercializing proprietary technologies by creating innovative means to deliver the experience and benefits of cannabis and hemp. Scientists at Infusion Biosciences have discovered the presence of, and developed methods to recover (APP Technology), water soluble forms of lipids (oils), including cannabinoids and terpenes, which naturally exist in the cannabis plants and are able to be delivered at scale in an ingredient known as Infuz₂O. Its APP Technology is being commercialized in Canada and other international markets via its licensee Sproutly Inc., which trades on the CSE under the ticker CSE:SPR. For more information, visit www.infusionbiosciences.com.

About Beverage Marketing Company

Beverage Marketing Group (“BMC”) is a New York City-based consulting, research and advisory services firm dedicated to the global beverage industry. BMC’s research/analytics group offers more than 30 market reports on trends in the beverage and allied industries. For more information, visit www.beveragemarketing.com

Forward-Looking Statements

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or believes regarding future events of management of Infusion Biosciences. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions. These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, and other factors, many of which are beyond the control of Infusion Biosciences. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.